Similarly, anti-EphA3 bound nanoparticles loaded with the DNA alkylation agent temozolomide showed tumor targeting, enhanced tumor cell death and increased survival in a rat glioma model [50]. This evidence concerns the gene EPHA3 and neoplasm.